{"text": ["Novartis,", "Amgen", "in", "dispute", "over", "migraine", "drug", "partnership"], "created_at": "2019-04-04 21:16:55"}
{"text": ["Top", "Analyst", "Reports", "for", "Amazon,", "3M", "&", "Novartis"], "created_at": "2019-04-04 21:05:09"}
{"text": ["Top", "Analyst", "Reports", "for", "Amazon,", "3M", "&", "Novartis"], "created_at": "2019-04-04 21:05:09"}
{"text": ["3", "Ways", "to", "Buy", "Into", "the", "Marijuana", "Boom", "Without", "the", "Risk"], "created_at": "2019-04-04 21:02:04"}
{"text": ["3", "Ways", "to", "Buy", "Into", "the", "Marijuana", "Boom", "Without", "the", "Risk"], "created_at": "2019-04-04 21:02:04"}
{"text": ["1", "Biotech", "That", "Biogen", "Should", "Buy", "...", "but", "Probably", "Won&apos;t"], "created_at": "2019-04-04 18:49:00"}
{"text": ["Top", "Analyst", "Reports", "for", "Amazon,", "3M", "&", "Novartis"], "created_at": "2019-04-04 18:19:06"}
{"text": ["Achillion", "Meets", "Enrollment", "Target", "in", "Kidney", "Disease", "Studies"], "created_at": "2019-04-04 17:05:52"}
{"text": ["Achillion", "Meets", "Enrollment", "Target", "in", "Kidney", "Disease", "Studies"], "created_at": "2019-04-04 17:05:52"}
{"text": ["Novartis", "Resubmits", "BLA", "to", "FDA", "for", "Biosimilar", "of", "Neulasta"], "created_at": "2019-04-04 16:09:48"}
{"text": ["Novartis", "Resubmits", "BLA", "to", "FDA", "for", "Biosimilar", "of", "Neulasta"], "created_at": "2019-04-04 16:09:48"}
{"text": ["Novartis", "sues", "Amgen", "over", "migraine", "treatment", "Aimovig"], "created_at": "2019-04-04 15:35:40"}
{"text": ["Achillion", "Meets", "Enrollment", "Target", "in", "Kidney", "Disease", "Studies"], "created_at": "2019-04-04 14:23:02"}
{"text": ["Novartis", "Resubmits", "BLA", "to", "FDA", "for", "Biosimilar", "of", "Neulasta"], "created_at": "2019-04-04 13:39:01"}
{"text": ["Novartis", "CEO&apos;s", "$50", "Billion", "of", "Deals", "Was", "Just", "the", "First", "Act"], "created_at": "2019-04-04 11:26:36"}
